Patrick Skeba is a Teaching Assistant Professor at the University of Pittsburgh's Department of Computer Science within the School of Computing and Information. He holds a PhD in Computer Science from Lehigh University (2022) and bachelor's degrees in Cognitive Science and Computer Science from Johns Hopkins University (2017). His research focuses on internet privacy, AI ethics, and the responsible use of data. He teaches courses in machine learning and programming. Research Interests: Skeba's work bridges technology and societal impact, emphasizing privacy risks in data systems, algorithmic fairness, and user-centric privacy frameworks. His recent studies explore informational friction in data collection, community-based privacy strategies, and lay-expert disparities in understanding privacy-enhancing technologies (PETs). Publications: His articles analyze privacy dynamics in digital spaces, from pandemic-era discourse on r/privacy to methodological approaches for categorizing technology non-use. His earlier work includes breakthroughs in sleep disorder diagnostics, particularly periodic leg movement (PLM) analysis and telemedicine applications for neurological conditions. Awards: No scientific awards listed. Grants and advising details are currently unspecified. Labs/Teams: No specific lab affiliations mentioned in provided materials. His teaching and research emphasize collaboration across computational and social domains.
Xihong Lin is a Professor of Statistics at Harvard University and a Professor of Biostatistics at the Harvard T.H. Chan School of Public Health. She is a distinguished academic, holding membership in both the National Academy of Sciences and the National Academy of Medicine. Her research focuses on scalable statistical inference for big data, statistical machine learning, causal inference, and integrative data analysis, with applications in genomics, public health, and precision medicine. Lin’s work addresses challenges in analyzing large-scale genomic and multi-ancestry data, including methods for rare variant association testing, ancestry-adjusted sample analysis, and scalable computing frameworks. Her contributions span biobank studies (e.g., UK Biobank, TOPMed) and clinical applications in lung cancer, cardiovascular health, and smoking cessation. Her scientific awards reflect her leadership in statistical genetics and public health. Key research trends include leveraging single-cell sequencing for functional genomics, developing ensemble machine learning methods for health subtyping, and enhancing polygenic risk prediction across diverse populations. Lin’s methodologies prioritize interpretability and scalability, enabling impactful analyses of complex observational and genomic datasets. Awards: Member, National Academy of Sciences; Member, National Academy of Medicine Her grants and advising efforts focus on interdisciplinary collaborations, bridging statistics, AI, and domain sciences. Lin leads initiatives to improve genomic data management and ethical use of federated data (e.g., FADI framework). She is affiliated with labs advancing statistical genetics and cloud-based workflows (e.g., STAAR workflow).
Dr. Kezhi (Ken) Li is an Associate Professor of AI in Healthcare at the Institute of Health Informatics, University College London (UCL). He leads the AI for Health research group and has established himself as a leading expert in applying artificial intelligence to solve complex problems in healthcare, with over 130 publications in leading journals (total impact factor greater than 400). Dr. Li earned his Doctor of Philosophy from Imperial College of Science, Technology and Medicine in 2013, followed by research positions at the Medical Research Council (2015-2017), University of Cambridge (2014-2015), and Royal Institute of Technology (KTH) (2013-2014). His academic journey reflects a consistent trajectory from technical AI research toward increasingly healthcare-focused applications. Dr. Li's research focuses on solving physiological, medical, clinical, and operational problems in healthcare using AI techniques. His specific expertise includes AI in healthcare using electronic health records (EHR), biomedical time series analysis using monitors/wearables, diabetes management, large language models (LLM) in healthcare (especially mental health), patient flow optimization, and digital health with federated learning. His work bridges the gap between cutting-edge AI methodologies and practical healthcare applications, with a strong focus on improving patient outcomes and healthcare system efficiency. Analysis of Dr. Li's publication history reveals a strong emphasis on diabetes management technologies, particularly blood glucose prediction systems using advanced neural network architectures. More recently, his work has expanded into mental health applications of large language models, blockchain-based federated learning for healthcare data, and mortality prediction in critical care settings. His research demonstrates a clear evolution from purely technical AI development toward increasingly clinically impactful applications, with growing emphasis on explainability, privacy preservation, and real-world implementation challenges. Dr. Li has received numerous prestigious awards recognizing his contributions to healthcare AI: Best Application Award of IEEE Global Blockchain Conference (2025) Fellow of British Computer Society (2025) Fellow of the Royal Society for Public Health (2024) Healthcare Partnership of the Year category at the London Higher Awards (2024) ECR Promising Project Award (2023) Gallivan Award finalists (2022) Stylianos Kalaitzis PhD Award Winner (2022) HDR UK Team of the Year (COVID-19) Award (2021) As an educator, Dr. Li serves as the Director of MRes study (AI-enabled Healthcare Systems) at UCL. He leads multiple key modules including Healthcare Artificial Intelligence Journal Club, Dissertation in Artificial Intelligence Enabled Healthcare, and Advanced Machine Learning for Healthcare. His supervision extends across dissertation projects and junior researchers in his AI for Health group. His research has been supported by various grants, including those from HDR UK, focusing on translating AI innovations into practical healthcare solutions. Dr. Li leads the AI for Health research group (https://ai4hucl.github.io/ai4h_webs/), which comprises researchers with diverse expertise in machine learning, healthcare systems, and clinical domains. The group maintains strong collaborations with healthcare providers and industry partners to ensure their research addresses real-world healthcare challenges and can be effectively translated into clinical practice.
Danielle Butler is a Visiting Fellow at the National Centre for Epidemiology and Population Health, Australian National University, and a part-time General Practitioner/Researcher at the Institute of Urban Indigenous Health. With 20+ years clinical experience and a PhD (2018), her work focuses on healthcare access equity for underserved populations through linked data analysis, mixed-methods research, and telehealth evaluation. Current projects: Enhancing Safe Telehealth , Patient-Centered Medical Homes , Primary Care Data Linkage Key collaborations: ANU, IUIH, Australian Institute of Health and Welfare Her research combines multilevel modeling of administrative data with participatory action research to evaluate primary care innovations. Recent work examines telehealth impacts , out-of-pocket costs , and Aboriginal health service models . Publications span BMJ Open , BMC Health Services Research , and Health Policy , with emphasis on systematic reviews , linked data methodology , and health equity metrics . Research fingerprint shows dominant themes: Primary Health Care (100%), Aboriginal and Torres Strait Islander Health (66%), Health Services Research (49%), and Telehealth (100%).
Rafael Perera is a Professor of Medical Statistics at the Nuffield Department of Primary Care Health Sciences (NDPCHS), University of Oxford, where he has been since 2002. He holds leadership roles as Director of the Statistics Group and Director of Graduate Studies , overseeing academic leadership and methodological research. He is also a Statistical Editor of BMJ and BMJ Medicine , and a fellow at St Hugh’s College Oxford . Education : DPhil, MSc, MA Rafael’s research focuses on monitoring for managing long-term conditions (e.g., Type 2 diabetes, hypertension) and complex multimorbidity phenotypes . His work includes impact of extreme temperatures on health , meta-analysis methods , and methodology for infectious diseases . He leads large methodological groups and has been a PI on NIHR-funded infrastructure programs (BRC, ARC, MIC). Recent publications highlight his expertise in clinical prediction models , digital health interventions , and diagnostic test evaluation . His grants span applied research , global health transformation , and ageing research . Scientific Awards : National and international recognition for methodology development in clinical trials (NIHR Progress Report 2008/09) Rafael supervises DPhil and MSc students and leads a fully accredited Clinical Trials Unit . His editorial and policy influence extends to healthcare policy panels and the Centre for Evidence-Based Medicine as Director of Research Methodologies.
Sai Zhang is an Assistant Professor in the Department of Epidemiology at the University of Florida (UF), holding affiliations with the College of Public Health & Health Professions and College of Medicine. He is also an Affiliate Faculty in the J. Crayton Pruitt Family Department of Biomedical Engineering at the Herbert Wertheim College of Engineering. Previously, he was an Instructor at Stanford University School of Medicine and a Research Associate at the VA Palo Alto Epidemiology Research and Information Center (ERIC). Dr. Zhang completed his Ph.D. in Computer Science and Technology at Tsinghua University, followed by postdoctoral training in Dr. Michael Snyder’s lab at Stanford Genetics. His research integrates machine learning, genomics, and precision medicine to uncover genomic bases of complex diseases. Key focuses include developing algorithms for multiomic data analysis, modeling genotype-phenotype relationships, and leveraging deep learning for biological sequence analysis. His work emphasizes cell-type-specific mechanisms in diseases like ALS, coronary artery disease, and neurodegenerative disorders. Notable contributions include frameworks for polygenic risk scoring (e.g., PRS-Net), biomarker discovery for ALS, and tools for time-to-event prediction in neurological diseases. He leads the Zhang Laboratory, advancing computational systems for precision health applications.
Simon Crouch is a Senior Research Fellow in Biostatistics at the University of York's Health Sciences department. With a strong mathematical background from Cambridge and Warwick, he leads the analytics team within the Epidemiology and Cancer Statistics Group and works closely with the Haematological Malignancy Research Network (HMRN) and Cardiovascular Health team. His work focuses on statistical modeling of complex epidemiological data related to hematological malignancies. University of Cambridge: MA, MMath in Mathematics University of Warwick: PhD in Mathematics University of Lancaster: MSc in Medical Statistics Dr. Crouch specializes in the statistical modeling of complex epidemiological data, with particular focus on hematological malignancies. His research encompasses predictive modeling, event history analysis, and machine learning applications in cancer epidemiology. He has made significant contributions to understanding myelodysplastic syndromes, lymphoma classification, and survival analysis in blood cancers through population-based studies. His work often involves collaboration with international registries including the European Myelodysplastic Syndromes Registry (EUMDS) and the Haematological Malignancy Research Network. Analysis of his recent publications reveals a strong focus on myelodysplastic syndromes (MDS), with particular attention to risk stratification, survival analysis, and treatment outcomes. His work increasingly incorporates genomic and molecular data to refine disease classification and prediction models. The trend shows progression from purely statistical methodology development toward integrated translational research that combines clinical, genomic, and epidemiological data to improve patient outcomes. Extensive publication record with 113 research outputs including 66 articles, 21 patents, and numerous meeting abstracts Active participation in major international research consortia including MDS-RIGHT and ImmunAID Significant contributions to the development of statistical methodologies for cancer epidemiology Dr. Crouch actively supervises PhD students in mathematical and statistical modeling applied to cancer epidemiology, with particular interest in time-to-event models, complex longitudinal models, and simulation techniques. His research has been supported through multiple projects, including the European Myelodysplastic Syndromes Registry and the MDS-RIGHT project focused on facilitating informed decision-making in hemato-oncology. He contributes to the Advanced Health and Social Statistics module for postgraduate students at the University of York.
Mehmet Karahan is an Associate Professor in the Department of Cardiovascular Surgery at Gaziantep University Faculty of Medicine. He specializes in cardiovascular surgery with a focus on mechanical circulatory support, left ventricular assist devices (LVAD), heart transplantation, and endovascular procedures. His clinical and research work centers on innovative approaches to treating complex cardiac conditions. His educational background includes: Medical License (English Program): Hacettepe University Faculty of Medicine (2004-2011), Turkey Specialization in Cardiovascular Surgery: Health Sciences University, Ankara High Specialized Health Application and Research Center (2012-2017), Turkey Dr. Karahan's research interests span multiple areas within cardiovascular medicine. He has made significant contributions to the field of mechanical circulatory support, particularly focusing on left ventricular assist devices (LVAD) and their applications in both adult and pediatric patients. His work explores minimally invasive approaches to LVAD implantation, management of complications, and integration with other cardiac procedures. Additionally, he has expertise in endovascular aortic repair techniques, including complex cases involving traumatic injuries and challenging anatomies. His research also extends to heart transplantation, anticoagulation management, and thrombophilia in vascular disease. Analysis of Dr. Karahan's recent publications reveals a strong focus on advancing mechanical circulatory support technologies, particularly LVAD systems. His work addresses critical challenges in the field including pediatric applications, minimally invasive techniques, management of complications like pump thrombosis, and integration with other cardiac procedures. He has also made significant contributions to endovascular aortic repair, developing innovative techniques for complex cases. His research demonstrates a multidisciplinary approach that bridges surgical innovation with patient-centered outcomes. Dr. Karahan is an active member of several professional organizations: European Association for Cardio-Thoracic Surgery (EACTS) - Member since 2024 International Society for Heart and Lung Transplantation (ISHLT) - Member since 2023 National Association of Vascular and Endovascular Surgery - Member since 2020 Turkish Cardiovascular Surgery Association - Member since 2014 He has served as an editor for The Turkish Journal of Thoracic and Cardiovascular Surgery (2025). His clinical work involves complex cardiovascular procedures, with a particular emphasis on innovative approaches to mechanical circulatory support and endovascular interventions. Dr. Karahan has presented his research at numerous national and international conferences, contributing to the advancement of cardiovascular surgical techniques. His professional experience includes positions at Gaziantep University, Ankara Bilkent City Hospital, and Turkey High Specialization Hospital. He has also gained international experience through observer positions at Paracelsus Medical University-Nuremberg Clinic, Hannover Medical School, University of Geneva, and Harvard University.
John Z. Ayanian serves as the Alice Hamilton Distinguished University Professor of Medicine and Healthcare Policy at the University of Michigan, holding joint appointments as Professor of Internal Medicine in the Medical School, Professor of Health Management and Policy in the School of Public Health, and Professor of Public Policy in the Gerald R Ford School of Public Policy. As inaugural Director of the Institute for Healthcare Policy and Innovation (IHPI), he leads a consortium of 700 faculty members across 15 schools and maintains clinical practice as a general internist at Michigan Medicine. His academic foundation includes a Bachelor of Arts in history and political science from Duke University (1982), medical degree from Harvard Medical School (1987), and master's in public policy from Harvard Kennedy School (1987), followed by residency and fellowship at Brigham and Women’s Hospital and post-doctoral training in health services research at Harvard School of Public Health. Dr. Ayanian's research program investigates health equity, access to care, and quality of care with particular attention to social determinants including race/ethnicity, gender, socioeconomic status, and insurance coverage. His work critically examines Medicaid expansion impacts, Medicare Advantage disparities, and policy responses to health inequities, often utilizing large-scale claims databases and cross-institutional collaborations. Current projects include the federally-authorized evaluation of Michigan's Medicaid expansion program serving over 700,000 adults. Analysis of his 15 most recent publications (2025) reveals three dominant research thrusts: (1) Medicare Advantage vs Traditional Medicare comparisons across diverse clinical conditions, (2) Medicaid policy evaluation including unwinding impacts and expansion effects, and (3) innovative measurement of health equity through new indices and AI applications. His work consistently emphasizes methodological rigor in health services research while maintaining strong policy relevance. His scientific honors include: Election to the National Academy of Medicine Master status in the American College of Physicians John Eisenberg National Award for Career Achievement in Research Distinguished Investigator Award from AcademyHealth Election to Alpha Omega Alpha and Association of American Physicians Dr. Ayanian leads the federally-funded Healthy Michigan Plan evaluation team of 15 faculty members and serves as founding Editor-in-Chief of JAMA Health Forum, previously holding editorial positions at the New England Journal of Medicine. His research receives substantial federal support focused on health policy evaluation, with particular emphasis on vulnerable populations. He actively mentors students and junior faculty across multiple disciplines. As Director of IHPI, he fosters interdisciplinary collaboration across 15 schools at the University of Michigan. His leadership extends to center memberships in AI and Digital Health Innovation, Caswell Diabetes Institute, and Center for Global Health Equity, where he promotes data-driven solutions to health disparities through cross-campus partnerships and innovative research methodologies.
Dr. Michelle Lampl is the Charles Howard Candler Professor at Emory University and Director of the Emory Center for the Study of Human Health. She holds leadership roles in the Emory-Georgia Tech Predictive Health Initiative and the Center for Health Discovery & Well Being. Her academic career spans over three decades, with a focus on human growth and development from an interdisciplinary perspective. Dr. Lampl earned her PhD (1983) and MD (1989) from the University of Pennsylvania. Her research revolutionized understanding of growth patterns through her discovery of saltatory growth (spurt-based growth cycles). Current studies investigate genetic/environmental interactions influencing growth, including hormonal, nutritional, and immunological networks. Her research portfolio includes collaborations with international institutions like the University of Southampton (UK) and NIH-funded projects through NICHD. Over 100 peer-reviewed publications highlight her contributions to developmental origins of health and disease (DOHaD), fetal programming, and pediatric growth mechanisms. Dr. Lampl pioneered the undergraduate College programs in human health and co-developed Emory’s Predictive Health strategic plan. She launched the Predictive Health & Society minor and contributes to the Molecules to Mankind graduate program. Her awards include AAAS Fellowship (2010) and Emory’s top teaching honor. Key areas of impact: Established growth chart limitations through saltation theory Linked maternal nutrition to fetal growth trajectories Advocated for interdisciplinary health education
Ke Wu is a Professor in the Department of Computer Science and Engineering at the University of Michigan. Their research focuses on the intersection of machine learning, biostatistics, and healthcare technology, with an emphasis on mobile health interventions, causal inference, and Bayesian methods. They lead a small, hands-on research group mentoring PhD students and postdocs. Key interests include developing predictive models for health outcomes, improving treatment effect estimation, and leveraging mobile technology for caregiver support. Their work has addressed critical challenges in clinical decision-making, public health surveillance, and healthcare innovation. Research projects span synthetic data generation for electronic health records, mHealth app development for care partners of traumatic brain injury patients, and algorithmic fairness in reinforcement learning. Ke Wu emphasizes interdisciplinary collaboration and has contributed to global health studies, including analyses of pneumonia etiology in low-resource settings and the PERCH study. Their group's methodologies often integrate wearable sensor data and machine learning to address real-world health challenges. Advising priorities include fostering student independence while maintaining close mentorship, with expectations for consistent research productivity and professional development. Students are encouraged to pursue teaching roles (e.g., GSI positions) and internships aligned with career goals. Funding support for conference participation is available through institutional and external grants. Ke Wu's contributions extend to statistical methodology, including Bayesian latent class models and dynamic risk prediction frameworks. They actively engage in translational research, bridging computational methods with clinical and public health applications, and prioritize open-source software development to advance reproducible research practices.
Ruoqing Zhu is an Associate Professor in the Department of Statistics at the University of Illinois at Urbana-Champaign, with a primary appointment in the College of Liberal Arts & Sciences. He also serves as an inaugural member of the Carle Illinois College of Medicine, a Faculty Fellow at the National Center for Supercomputing Applications, and an affiliated researcher with the Carl R. Woese Institute for Genomic Biology and the Center for Genomic Diagnostics. His roles include PhD Program Director and Advisory Board member of Prenosis Inc. Dr. Zhu holds a Ph.D. in Biostatistics from the University of North Carolina at Chapel Hill (2013), an MA in Statistics from Bowling Green State University (2008), and dual B.S. degrees in Mathematics and Financial Engineering from Nanjing University (2006, 2005). His postdoctoral training was at Yale University’s Department of Biostatistics (2013–2015). His research focuses on developing statistical methods for decision-making in personalized medicine and reinforcement learning, addressing challenges such as model interpretability, high-dimensional data, and distributional shifts. Key areas include uncertainty quantification, causal inference, and applications in bioinformatics, nutrition, and infectious diseases. He co-teaches courses at Carle Illinois, including Data Science Project and Foundations: Molecules to Populations , and contributes to interdisciplinary initiatives like the Personalized Nutrition Initiative. His recent work emphasizes trustworthy AI in healthcare, including sepsis prediction tools, metabolomic analysis, and biomarker discovery. He is actively involved in translational research, bridging computational methods with clinical and public health applications.
Horst A. von Recum, PhD, is the Executive Vice Chair of the Case School of Engineering and a Professor in the Department of Biomedical Engineering at Case Western Reserve University. He is also a member of the Cancer Imaging Program at the Case Comprehensive Cancer Center. His research focuses on developing novel platforms for molecular and cellular delivery, including affinity-based systems for controlled drug release and directed stem cell differentiation. Key applications include HIV therapies, wound healing, ocular disease treatments, and tissue engineering. His work emphasizes improving drug delivery precision through molecular interactions and enhancing stem cell viability for therapeutic use. Dr. von Recum’s research interests span drug delivery systems, biomaterials science, and regenerative medicine. His lab explores cyclodextrin polymers for sustained antibiotic release, affinity-driven drug refilling mechanisms, and engineering biocompatible materials to combat implant-related infections. Recently, his team has investigated microbiome interactions with neural implants and developed polymer-based solutions for localized chemotherapy. Notable contributions include advancements in PMMA bone cement composites for drug refillable depots, cyclodextrin hydrogels for controlled release, and affinity-based systems for anti-fibrotic treatments. His work bridges materials science with clinical applications, addressing challenges in orthopedic infections, neural interfaces, and cardiovascular regeneration. Scientific achievements include over 100 peer-reviewed publications. Research funding has supported projects on antimicrobial coatings, drug delivery mechanics, and stem cell differentiation. Dr. von Recum collaborates across disciplines to translate biomaterial innovations into clinical solutions.
Karen Bandeen-Roche is a Professor and the Hurley-Dorrier Professor and Chair of the Department of Biostatistics at the Johns Hopkins Bloomberg School of Public Health, with joint affiliations in the School of Medicine and the School of Nursing. She is a leading expert in biostatistical methodology, particularly in latent variable models, longitudinal analysis, and multivariate survival methods applied to aging and gerontology. Her research focuses on developing statistical models for unobservable processes such as frailty, resilience, and functional status in older adults. She has made significant contributions to the measurement of aging-related constructs and has extensive collaborative work in ophthalmology and neurology. Her methodological work includes mixture models, measurement error correction, and latent class modeling. The recent publications highlight a strong trend in gerontological biostatistics, with a focus on frailty, dementia risk, resilience, and multisystem physiological responses in aging. Her work integrates complex data from observational cohorts and clinical studies, often employing innovative latent variable frameworks to address measurement challenges in health outcomes. Scientific Awards and Honors: Marvin Zelen Leadership Award in Statistical Science (2016) Fellow of the American Statistical Association (2001) Brookdale National Fellow (1997) Golden Apple Award for Excellence in Teaching (2010) Garland Clay Award (1999) Chair, NIH BMRD Study Section (2006–2008) President, Eastern North American Region, International Biometric Society (2011–2013) Executive Board, International Biometric Society (2015–2022) Board of Directors, National Institute of Statistical Sciences (2020–2023) Karen Bandeen-Roche has been deeply involved in advising and training the next generation of researchers. She co-directs a training program in Biostatistics and Epidemiology of Aging and has received multiple teaching and mentoring awards. She has served on numerous academic committees, including appointments and promotions, faculty senate, and ethics committees at Johns Hopkins. Her grants and collaborative research span aging, dementia, ophthalmology, and cardiovascular health, often supported by NIH and other federal agencies. She leads the Center on Aging and Health and is actively involved in interdisciplinary research initiatives that bridge biostatistics, medicine, and public health. Her lab and research team focus on developing and applying advanced statistical methods to understand the biological and social determinants of healthy aging.
Professor Emanuele (Manuel) Trucco is the NRP Chair of Computational Vision in the Department of Computing, School of Science and Engineering, at the University of Dundee. He holds additional roles as an Honorary Clinical Researcher at NHS Tayside and formerly served as an Adjunct Professor at the Chinese Academy of Sciences from 2018 to 2021. He earned his MSc and PhD in Electronic Engineering from the University of Genoa, Italy, in 1984 and 1990, respectively. His research focuses on medical image and data analysis, particularly in retinal imaging, using machine and deep learning techniques. He is co-director of VAMPIRE, a major international initiative in retinal image analysis, which supports biomarker studies in cardiovascular disease, diabetes, dementia, and neurodegenerative disorders. His recent work includes AI-driven tools for predicting dementia from brain scans and cardiovascular risk from retinal images. The latest publications reflect strong trends in applying deep learning to retinal and brain imaging for early disease detection, with themes centered on AI in healthcare, precision medicine, and non-invasive diagnostics. FRSA (Fellow of the Royal Society of Arts) FIAPR (Fellow of the International Association for Pattern Recognition) Professor Trucco has led and co-led significant research projects funded by EPSRC, NIHR, and EU programs. He has supervised PhD students through industry-sponsored studentships (e.g., OPTOS, NIDEK, Toshiba) and collaborated with institutions such as the Universities of Edinburgh and Liverpool. His research is supported by extensive industrial partnerships including Canon Medical, Epipole plc, and NIDEK. He is a key member of the UK Biobank Eye and Vision Consortium and co-director of the VAMPIRE initiative, a collaborative effort between the Universities of Dundee and Edinburgh focused on retinal image analysis. His work also involves participation in major research networks such as the Academic Health Science Partnership in Tayside.
